Drug Database
Back to search

Canada· CA-DIN-02230575

AMETOP GEL 4%

A tetracaine product containing tetracaine (tetracaine hydrochloride), registered in Canada by VALEO PHARMA INC. The same ATC class is registered in 4 of our 19 countries.

ATC D04AB06

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedAMETOP GEL 4%ATCD04AB06REGISTER NO.CA-DIN-02230575PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tetracaine (tetracaine hydrochloride)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tetracaine is registered in 4 of 19 countries.

Countries holding a registration under ATC D04AB06 (tetracaine), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 1 of them publish a price we can compare per daily dose
Search tetracaine products by name

Tetracaine · ATC D04AB06

4 / 19 countries

  • Canada
  • Germany
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TETRACAINE (TETRACAINE HYDROCHLORIDE)
Manufacturer
VALEO PHARMA INC
Country
Canada (CA)
ATC code
D04AB06
ATC class
Tetracaine
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

36 interactions on record for tetracaine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tetracaine against other medicinesHow interaction checks work

Tetracaine · interactions on record

36 records

  • 1 severe
  • 35 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • MetoclopramideA03FA01moderate
  • LidocaineC01BB01moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tetracaine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetracaine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited, Minims Tetracainehydrochloride Bausch + Lomb Ireland Limited
  • Germany · Tetracain-Hcl Smartpractice Europe
  • Spain · Lubristesic, Tetracaína Lainco
  • France · Tetracaine Thea
  • United Kingdom (Northern Ireland) · Ametop, Anethaine
  • Greece · Tetracaine Hydrochloride Cooper
  • Ireland · Ametop, Minims
  • Luxembourg · Minims, Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited
  • Netherlands · Minims Tetracainehydrochloride, Tetracaïnehydrochloride Minims Bausch + Lomb Ireland
  • Norway · Tetrakain Minims Bausch + Lomb Ireland Limited
  • Sweden · Tetrakain Bausch & Lomb

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/937fa35a-cf7a-4c02-87e4-41526276627c
GET /v1/drugs/937fa35a-cf7a-4c02-87e4-41526276627c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02230575",
  "form": "GEL",
  "class": "Human",
  "routes": [
    "TOPICAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "D04AB06",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "49664",
  "strengths": [
    "40 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "TETRACAINE (TETRACAINE HYDROCHLORIDE)"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about tetracaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console